DIC is the abbreviation of disseminated intravascular coagulation, which is related to infections and malignant tumors, and patients are prone to bleeding, hypotension and other symptoms, and need to actively cooperate with doctors for treatment.
Disseminated intravascular coagulation can be caused by a variety of reasons, such as bacteria, viruses, fungi and other serious infectious diseases, lung cancer, pancreatic cancer and other malignant tumors, as well as heat stroke, carbon monoxide poisoning and other systemic diseases. The main clinical manifestations of the disease are spontaneous and multiple bleeding, such as skin petechiae, bleeding gums, hematuria, etc. Patients may show wet and cold limbs, oliguria, hypotension, drowsiness, coma, respiratory distress, shock, and so on.
Clinically, for patients with early disseminated intravascular coagulation, extensive microthrombosis is mainly inhibited by applying heparin-like drugs such as tunicamycin and low molecular heparin. In the middle stage of the disease, blood products such as fresh whole blood and platelet suspension need to be appropriately transfused, and in the late stage, antifibrinolytic drugs such as aminomethylenic acid and tranexamic acid can be applied.
Disseminated intravascular coagulation is a critical hematologic condition, so after the diagnosis of the disease, it is necessary to actively comply with the doctor’s instructions for treatment, and most of the patients’ symptoms can be improved. If treatment measures are not taken in time, it will easily cause acute renal failure, respiratory distress syndrome, etc., which can be life-threatening.